Timing is everything for some. AI wasn’t going to get timing right anymore than anyone else which is why waiting it out is the name of the game and something I have said I would do since the beginning. I have said to watch manufacturing updates for clues for quite some time. Once L is approved it will signal that manufacturing at viable commercial ramp scale up is truly in sight. Until then it is my opinion that the clues are all floaters that can’t help sustain share price. Now other news could come right before or in conjunction with this but what makes personalized medicine a viable investment is the ability to become available to all who need it and want it. You can’t get there without the right process for manufacturing to get costs in line with ability to pay for it and right regulatory structure to reduce impediments to access. I doubt AI would have figured this out 10 years ago but I do recall a person mentioning in 2015 something about 10 years before approval and Linda saying that was not a likely target yet here we are; ). I think it was a bear; ). Best wishes.
Market Data 
Markets 
AI
